The ALS Association is proud to announce that our President and CEO, Calaneet Balas, has been elected to the National Health Council (NHC) Board of Directors for a three-year term.
If passed, The HEALTHY BRAINS Act would create a center at the National Institutes of Health (NIH) to conduct research on environmental and occupational risk factors for ALS and develop strategies to minimize those risks.
The ALS Association told the Secretary of the Department of Transportation (DOT) about the horrible experiences of ALS advocates when flying. This is part of our effort to make air travel safe and accessible for people living with ALS.
The ALS Association and Focused Ultrasound Foundation have partnered to support a small pilot clinical study that will leverage focused ultrasound technology as part of a new ALS treatment approach. The study will be led by Agessandro Abrahao, M.D., an assistant professor of neurology at the University of Toronto and an associate scientist at Sunnybrook Research Institute.
The American Academy of Neurology, The ALS Association and the American Brain Foundation have awarded the 2024 Sheila Essey Award to Eva Feldman, M.D., Ph.D., from the University of Michigan. Throughout her distinguished career, Feldman has shed light on biological processes that drive ALS development and progression, paving the way for the development of new therapies, including two first-ever human clinical trials of intraspinal stem cell implantation (injection) therapy for ALS.
Partnership with leading US-based ALS patient advocacy group furthers myTomorrows’ mission of ensuring that patients confronting life-threatening diseases are aware of all possible treatment options
On behalf of everyone living with ALS and their families, the ALS Association sent a letter this week to members of the House and Senate demonstrating our support for the passing of the ALS Better Care Act which will increase access to multidisciplinary care clinics for people living with ALS.